Institutional
9 de August de 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Back
Share:
Last related news
30 de July de 2026
Raquel Barros Appointed Member of the National Council for Combating Piracy
Kasznar Leonardos is proud to share that Raquel Barros, Partner and Co-Head of Anti-Piracy & Brand Protection, has been elected as one … Raquel Barros Appointed Member of the National Council for Combating Piracy
7 de April de 2026
Kasznar Leonardos was ranked in Chambers Brazil: Contentious 2026
We are proud to announce that we have been ranked in Chambers Brazil: Contentious 2026 by Chambers and Partners. As a firm, … Kasznar Leonardos was ranked in Chambers Brazil: Contentious 2026
13 de March de 2026
Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation
Our firm successfully represented a company operating in the offshore oil and gas sector in a lawsuit challenging the validity of a Brazilian patent … Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation